You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2011 or most recent year available
Part (i) All clients by country and primary drug and type of treatment unit
| Country | Amphetamines | MDMA and other derivatives | |||
|---|---|---|---|---|---|
| Outpatient | Inpatient | Outpatient | Inpatient | ||
| Belgium | 365 | 87 | 31 | 4 | |
| Bulgaria | 9 | 6 | 2 | 0 | |
| Czech Republic | 904 | 1545 | 2 | 1 | |
| Denmark | 341 | 17 | 13 | 0 | |
| Germany | (1) | 0 | : | 0 | : |
| Estonia | : | : | : | : | |
| Ireland | (2) | 34 | 7 | 27 | 13 |
| Greece | 5 | 1 | 6 | 2 | |
| Spain | (2) | : | : | : | : |
| France | 98 | 1 | 115 | 3 | |
| Italy | (3) | 38 | : | 129 | : |
| Cyprus | 1 | 1 | 2 | 0 | |
| Latvia | (4) | 380 | : | 2 | : |
| Lithuania | (1) | : | : | : | : |
| Luxembourg | : | : | : | : | |
| Hungary | 388 | 74 | 36 | 8 | |
| Malta | : | : | : | : | |
| Netherlands | : | 128 | : | 4 | |
| Austria | 64 | 19 | 17 | 2 | |
| Poland | (5) | 66 | 207 | 1 | : |
| Portugal | (6) | 1 | : | 4 | : |
| Romania | 3 | 2 | 0 | 9 | |
| Slovenia | 2 | : | 1 | : | |
| Slovakia | 273 | 257 | 0 | 1 | |
| Finland | 106 | 98 | 3 | 1 | |
| Sweden | (2) | 546 | 918 | 8 | 10 |
| United Kingdom | (7) | 3364 | 59 | 227 | 2 |
| Croatia | 76 | 4 | 22 | 1 | |
| Turkey | : | 18 | : | 1 | |
| Norway | (1) | 0 | 0 | 0 | 0 |
Notes:
: Indicates data are not available.
(1) Only aggregated data for stimulants (other than cocaine) are available.
(2) Last data available refer to 2010.
(3) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.
(4) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.
(5) Category amphetamines includes both amphetamine and methamphetamine. Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.
(6) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria.
(7) Data are from 1st of April 2010 to 31st March 2011.
The number of treatment clients in each country is listed in Table TDI-7.
See also 'General notes for interpreting data’ on the Explanatory notes and help page.
Sources:
Reitox national reports 2012 — TDI. See Table TDI-0 for details on sources.